|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/454 | |||
| A01N 43/04 | |||
| A01N 61/00 |
| (11) | Patento numeris | 1876893 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06750227.8 |
| Europos patento paraiškos padavimo data | 2006-04-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-04-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/014137 |
| Data | 2006-04-14 |
| (87) | Numeris | WO 2006/113470 |
| Data | 2006-10-26 |
| (30) | Numeris | Data | Šalis |
| 671630 P | 2005-04-15 | US |
| (72) |
MOORE, Malcolm, A., S., US
CHIN, Allison, C., US
|
| (73) |
GERON CORPORATION,
230 Constitution Drive, Menlo Park, CA 94025,
US
MEMORIAL SLOAN-KETTERING CANCER CENTER, 1275 York Avenue, New York, NY 10021, US |
| (54) | CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES |
| CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES |